All components have been completely validated and comply with GCP and 21 CFR Part 11, including complete audit trail tracking. ICOSpeedRead has been sent to FDA and currently is in use for recent oncology submissions.
ICOSpeedRead allows protocol specific configuration and allows ICON Medical Imaging to begin reading within two weeks. No other competitor offers these components, in this time frame, with this level of quality.